Pharmaceutical

Several months after unveiling its direct-to-consumer NovoCare Pharmacy service with the launch of a $499 cash-pay option for a monthly supply of Wego...

An appeals court overturned a prior FDA action in a years-long face-off between Vanda and the agency over a delayed hearing for Vanda's jet lag disord...

Sarepta Therapeutics has provided additional safety data on its gene therapy Elevidys as a Duchenne muscular dystrophy patient group petitions the FDA...

Roche has found redemption in a precision medicine approach following an earlier Tecentriq trial flop in a broader bladder cancer population.

The FDA clearance sets Novo’s medicine up a market battle with Madrigal Pharmaceuticals’ fast-selling Rezdiffra.

The drug, which functions similar to psilocybin, scored positive enough results in a mid-stage study that Reunion is now setting up a larger experimen...

Scientists say HHS’ decision to defund mRNA vaccine research will leave the country less prepared for pandemics, and make it harder to invest in compa...

The biotech, which cut jobs following the rejection in May of its Barth syndrome therapy, claimed it has addressed the agency’s concerns and now sees...

Tough times in the industry are forcing changes in investment and governance that should result in a healthier sector, the Omega Funds founder said.

Lilly’s study finds tirzepatide delivers broader health improvements Lilly’s study finds tirzepatide delivers broader health improvements